Evidence map›Paper›PMID 33505580›Full record

ArticleOxidative medicine and cellular longevity2021

Exosomes Released from CaSR-Stimulated PMNs Reduce Ischaemia/Reperfusion Injury.

Tai-Yu Zhai, Bao-Hong Cui, Yang Zhou, Xin-Yu Xu, Lei Zou, Xin Lin, Xiao-Shuang Zhu, Si-Wen Zhang, Wan-Lin Xie, Yang-Yang Cheng and 1 more

RetractedOpen access · hybridAbstract readRetracted Publication
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. New Developments in Exosomal lncRNAs in Cardiovascular Diseases.Frontiers in cardiovascular medicine · 2021
    Review
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Tai-Yu ZhaiDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.ORCID https://orcid.org/0000-0003-2843-7047
Bao-Hong CuiDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Yang ZhouDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Xin-Yu XuDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Lei ZouDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Xin LinDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Xiao-Shuang ZhuDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Si-Wen ZhangDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Wan-Lin XieDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Yang-Yang ChengDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.
Yi-Hua SunDepartment of Clinical Laboratory, Harbin Medical University Cancer Hospital, Harbin 150086, China.ORCID https://orcid.org/0000-0001-8027-2927
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemia-reperfusion (I/R) injury caused by acute myocardial infarction (AMI) can initiate a strong inflammatory response. Polymorphonuclear cells (PMNs) are the most important inflammatory cells. Our previous studies found that the calcium-sensing receptor (CaSR) regulates the proinflammatory effects of PMNs. However, the role and mechanism of CaSR-regulated PMNs in I/R injury remain uncertain. A rat AMI model was developed in this study and showed that the expression of CaSR on PMNs increased in AMI; however, the levels of Bcl-xl and SOD in myocardial tissue decreased, while Bax and MDA levels increased. Then, after coculture with CaSR-stimulated PMNs, the expression of Bcl-xl in cardiomyocytes significantly increased, Bax expression and the apoptotic rate decreased, and ROS production was significantly inhibited. At the same time, the cardiomyocyte damage caused by hypoxia-reoxygenation was reduced. Furthermore, we found that exosomes derived from PMNs could be taken up by cardiomyocytes. Additionally, the exosomes secreted by CaSR-stimulated PMNs had the same effect on cardiomyocytes as CaSR-stimulated PMNs, while the increased phosphorylation level of AKT in cardiomyocytes could be revered by AKT transduction pathway inhibitors. Subsequently, we identified the exosomes derived from CaSR-stimulated PMNs by second-generation sequencing technology, and increased expression of lncRNA ENSRNOT00000039868 was noted. The data show that this lncRNA can prevent the hypoxia-reoxygenation injury by upregulating the expression of PDGFD in cardiomyocytes. In vivo, exosomes from CaSR-stimulated PMNs played a significant role against AMI and reperfusion injury in myocardial tissue. Thus, we propose that exosomes derived from CaSR-stimulated PMNs can reduce I/R injury in AMI, and this effect may be related to the AKT signaling pathway.

Indexed as

AnimalsAnimals, NewbornApoptosisCells, CulturedExosomesHypoxiaMyocardial Reperfusion InjuryMyocytes, CardiacNeutrophilsOxygenRatsRats, WistarReceptors, Calcium-SensingSignal Transductionextracellular calcium cation-sensing receptor, ratOxygenReceptors, Calcium-Sensing

Identifiers

PMID33505580
PMCPMC7815400
OpenAlexW3118965856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.